Literature DB >> 9527888

Induction of calcitonin gene-related peptide-like immunoreactivity in hippocampal neurons following ischemia: a putative regional modulator of the CNS injury/immune response.

K Bulloch1, T A Milner, A Prasad, M Hsu, G Buzsaki, B S McEwen.   

Abstract

Calcitonin gene-related peptide (CGRP) is a potent vasodilator and immune cell modulator. In two studies within the hippocampal formation (HF), CGRP-like immunoreactivity (CGRP-LI) was increased in the inner molecular layer of the dentate gyrus after adrenalectomy and in mossy cells after colchicine-induced destruction of granule neurons. Given the increase in CGRP-LI following damage to the granule cell region of the HF, we investigated another trauma model, ischemia, that targeted different areas of the HF, CA1 region, and subiculum to ascertain the regional expression of this peptide after insult. Following ischemia, light microscopic evaluation showed CGRP-LI in basket cell-like neuronal perikarya within the dorsal subiculum and CA1 region of the hippocampus and in varicose fibers within the CA2 region of the hippocampus. Control rats rarely expressed CGRP-LI within neurons in these regions. In ischemic brains, double-labeled immunocytochemistry with antibodies to various neural markers demonstrated co-localization of CGRP-LI primarily within surviving subicular and CA1 cells resembling interneurons containing parvalbumin-LI or calbindin-LI. Electron microscopic analysis of the CA1 region from ischemic brains showed that CGRP-LI was contained in terminals with numerous small synaptic vesicles that formed symmetric synapses with perikarya and large dendrites of pyramidal cells, some of which were degenerating. Collectively, the data from this study and our previous study indicate that damage induces CGRP-LI expression in interneurons and nonprincipal cells in the area of damage, and we hypothesize that CGRP expression in surviving neurons within damage-related regions of the hippocampus is likely to be an important, and possibly a protective, component of the response of the nervous system to injury. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9527888     DOI: 10.1006/exnr.1997.6765

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

Review 1.  Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens.

Authors:  Esther M Sternberg
Journal:  Nat Rev Immunol       Date:  2006-04       Impact factor: 53.106

2.  Calcified Neurocysticercosis and Headache in an Endemic Village: A Case-Control Study Nested to a Population-Based Cohort.

Authors:  Oscar H Del Brutto; Ana M Robles; Robertino M Mera; Aldo F Costa; Elizabeth Darsan; Lucía Milla; Jessica Montes; Julio Lama; Victor J Del Brutto; Mauricio Zambrano; Mark J Sedler
Journal:  Am J Trop Med Hyg       Date:  2018-06-21       Impact factor: 2.345

Review 3.  Epilepsy as an example of neural plasticity.

Authors:  Helen E Scharfman
Journal:  Neuroscientist       Date:  2002-04       Impact factor: 7.519

4.  Tonic activation of A(2A) adenosine receptors unmasks, and of A(1) receptors prevents, a facilitatory action of calcitonin gene-related peptide in the rat hippocampus.

Authors:  A M Sebastião; M P Macedo; J A Ribeiro
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

5.  Characterization of meningeal type 2 innate lymphocytes and their response to CNS injury.

Authors:  Sachin P Gadani; Igor Smirnov; Ashtyn T Smith; Christopher C Overall; Jonathan Kipnis
Journal:  J Exp Med       Date:  2016-12-19       Impact factor: 14.307

Review 6.  The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury.

Authors:  Annabel J Sorby-Adams; Amanda M Marcoionni; Eden R Dempsey; Joshua A Woenig; Renée J Turner
Journal:  Int J Mol Sci       Date:  2017-08-17       Impact factor: 5.923

7.  Calcitonin gene-related peptide pre-administration acts as a novel antidepressant in stressed mice.

Authors:  Narumi Hashikawa-Hobara; Takumi Ogawa; Yusuke Sakamoto; Yumi Matsuo; Mami Ogawa; Yoshito Zamami; Naoya Hashikawa
Journal:  Sci Rep       Date:  2015-08-07       Impact factor: 4.379

8.  Effect of ropivacaine on peripheral neuropathy in streptozocin diabetes-induced rats through TRPV1-CGRP pathway.

Authors:  Nanwen Zhang; Haixiang Wei; Weifang Wu; Peimin Lin; Yuan Chen; Zhiwei Liu; Honglin Wang; Yize Bian; Kai Yu; Shan Lin; Yanqi Cui; Renwei Luo; Jianming Lin; Xiaole Chen
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.